Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Immunity Against Staphylococcus Aureus Skin Infection
NCT02262819Phase 1Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Oct 2014
- Primary completion
- Apr 2019
- Countries
- 1
01
Overview
Phase 1, open-label trial, sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoints: Local in vivo skin immune response to bacteria at 4 years and Keratinocyte responses to bacterial challenge at 4 years. Started Oct 2014; status: completed.
Beyond the preview
Go deeper on NCT02262819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02262819.